[NEWSMP] There is keen interest in the outlook of the pharmaceutical manufacturing industry, as recent survey results from the Bank of Korea and the Korea Institute for Industrial Economics & Trade (KIET) show divergent views.According to the Bank of Korea’s recently released September 2024 Business

[NEWSMP] As the medical supplies index rose sharply, exceeding the 16,000 mark for the first time in nearly two years, the combined market capitalization of 47 constituent stocks also surpassed 150 trillion won.In particular, 12 of the 47 constituents of the medical supplies index gained more than 1

[NEWSM] PAmid global Big Pharma continues to recover from the impact of the COVID-19 endemic, obesity treatments are creating a new landscape.According to second-quarter reports from major global Big Pharma companies compiled by Newsmp, most of them expanded their growth compared to the first quarte

[Newsmp] Huonslab, a subsidiary of Huons Global Co., Ltd., S. Korea announced the grant of process patent on the manufacturing methods of recombinant human hyaluronidase (HyDIFFUZE™), which facilitates the conversion of IV injection to SC Injection.The patent grant secures Huonslab an optimized cell

[NEWSMP] The pharmaceutical and biotech stocks, which struggled throughout the first half of the year, have been surging after entering the second half.According to the Korea Exchange, one-quarter of the top 100 stocks in terms of share price change in the KOSPI market from July 1th to the July 12th

[NEWSMP] In the first half of the year, the number of drugs (including biologics) approved by the Ministry of Food and Drug Safety decreased by nearly 20% from the same period last year.According to the Ministry of Food and Drug Safety, a total of 187 companies received approval for 627 drugs in the

[NEWSMP] In the first quarter, more than half of the top pharmaceutical companies saw an increase in merchandise sales portion. However, the average merchandise sales portion decreased slightly. (Based on separate financial statements)Newsmp compiled merchandise sales portion through quarterly repor

[NEWSMP] While the performances of global big pharma companies have been mixed, they are increasing their growth rate, emerging from the impact of COVID-19.According to the first quarter report of major global big pharma companies compiled by Newsmp, Novo Nordisk and Lilly maintained strong growth,

[NEWSMP] Despite the medical crisis in the first quarter, top pharmaceutical companies reported satisfactory financial results. However, the results were quite mixed by company.While all of the top five pharmaceutical companies reported preliminary first-quarter results, Newsmp compiled the sales an

[NEWSMP] 7 stocks up double digits in Medical Supplies index...47 constituents combined market capitalization returned to 130 trillion levelThe combined market capitalization of the 47 constituents of the Medical Supplies index has recovered to the 130 trillion won level.According to the Korea Exch

[NEWSMP] Even as global big pharma’s growth has slowed down as the COVID-19 pandemic winds down, the burden of R&D expenses for big pharma has increased significantly.Newsmp recently compiled reports from the major global big pharma companies that have released their annual results for 2023, and fou

[NEWSMP] The maximum reimbursement amount for Chong Kun Dang's Lucentis biosimilar Lucen-BS will be reduced by 50%, while the maximum reimbursement amount for JW Pharmaceutical's Dulackhan Easy Syrup will be increased by 20.24%.Novartis' Luxturna, a treatment for inherited retinal dystrophy, Bayer's

[Newsmp] The price index for cold medicines in South Korea has increased by more than 20% since the start of the COVID-19 pandemic in 2020.Among other pharmaceutical products, the price index for digestants soared by more than 10% alone last year.South Korean pharmaceutical prices rose by 2.3% in De

[Newsmp] The Korean Ministry of Food and Drug Safety (MFDS) granted fewer than 200 drug patents in 2023.According to the MFDS information platform (https://nedrug.mfds.go.kr/), the number of drug patents registered with the MFDS decreased by 80 cases from 278 cases in the previous year to 198 cases.

[Newsmp] South Korea's pharmaceutical exports fell to $7.87 billion in 2023, down 24.9% from the previous year.The overall biohealth export value of decreased by 18.0% to $13.35 billion in the same period.However, the export value of pharmaceuticals and the biohealth industry, which had been in decl

[Newsmp] Last year, HanAll Biopharma, JW Pharmaceutical and Chong Kun Dang Pharmaceutical were the top 100 stocks in terms of stock price increase among the 930 listed stocks on the KOSPI market.According to the Korea Exchange, HanAll Biopharma ranked 15th on the stock price leaderboard in 2023 with

[Newsmp] Pfizer's leukemia treatment Bosulif (ingredient: bosutinib), AstraZeneca's neurofibromatosis treatment Koselugo (ingredient: selumetinib), and Ono Pharma Korea's colorectal cancer treatment Braftovi (ingredient: encorafenib) will benefit from insurance coverage on the first day of the new y

[Newsmp] The Korean government has established new coverage standard for Levofloxacin injection drug Cravit Inj. (Jeil Pharmaceutical) and oral drug Levofexin (Il Dong Pharmaceutical), and expanded coverage standard for Doxycycline Vibramycin-N (Pfizer), in response to the spread of Mycoplasma pneum

[Newsmp] The reimbursement standard for BMS’ ulcerative colitis treatment Zeposia (ingredient: ozanimod), Kolon Pharma’s triple combination in a single inhaler for the treatment of chronic obstructive pulmonary disease (COPD) Trimbow (ingredient: beclometasone/formoterol/glycopyrrolate), and AstraZe

[Newsmp] The number of cancer patients hospitalized has increased sharply this year, as the COVID-19 pandemic has subsided.Cancer hospitalization and treatment cases in South Korea have surged by 25.0% in the first three quarters of this year, reaching 422,518, according to the Health Insurance Revi